Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
about
Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder.Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis.Microglia Gone Rogue: Impacts on Psychiatric Disorders across the Lifespan.Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.
P2860
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
@en
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
@nl
type
label
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
@en
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
@nl
prefLabel
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
@en
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial.
@nl
P2093
P2860
P356
P1476
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial
@en
P2093
Ajeet B Singh
Atapol Sughondhabirom
Buranee Kanchanatawan
Chee Hong Ng
Deidre J Smith
Gin S Malhi
Helen McKenzie
Lesley Berk
Michael Berk
Mohammadreza Mohebbi
P2860
P304
P356
10.1177/0004867417709357
P577
2017-06-03T00:00:00Z